Only 2 days until the launch of the Biopharmaceutical Competitiveness & Investment (BCI) Survey 2025 (Latin America). We invite you to stay tuned for the results of this report, which could help shape the future of biopharmaceutical competitiveness in LATAM! #BCI2025
The 13th edition of the US Chambers Global IP Index is now launched. This year, the Global IP Index covers 55 economies across 53 indicators, recognizing the wide and profound impact IP has on innovation, creativity, and on our lives in general. https://t.co/Zss8ej0r9C
Yesterday Professor Pugatch spoke to an audience of Swedish life
sciences stakeholders on the EU’s capacity to compete in the global life
sciences innovation race | read more at https://t.co/j9Yp3sQUcr
Dr David Torstensson presents
the findings of the 2019 Global Rule of Law and Business Dashboard at the U.S. Chamber of Commerce in Washington D.C. https://t.co/dkgPXJR2dv #PConsilium
How should policy frameworks be designed and implemented to ensure a sustainable European market for off-patent biologic? New study by Pugatch Consilium provides an answer available @EFPIA#Biosimilars#SustainableMarket https://t.co/9A7wRppEt0
Professor Meir Pugatch spoke last week at the forum “How to Accelerate Taiwan Biomedical Policy Momentum as an Asia-Pacific Biomedical R&D Hub” hosted by the International Research-based Pharmaceutical Manufacturers Association (IRPMA) read more at https://t.co/henuwZPBVI
Pugatch Consilium is releasing today a new study - Benchmarking Success: Evaluating the Orphan Regulation and its impact on patients and rare disease R&D in the European Union. Read more on our website at https://t.co/g9lBV7KuHc
A snapshot to IPHA’s 25th Annual Conference: ‘Patient Care, Powered By Innovation’. Congratulations @IPHA for a successful event!
Watch the video at https://t.co/RxJyyDz3ox
Study released today commissioned by the Biotechnology Innovation Organization (BIO) highlights strategies, policies and best practices that have been successful in creating an environment in which biotechnology innovation can flourish around the world https://t.co/KAGtVQQ6Nq
Ireland remains a manufacturing powerhouse, yet punches
below its weight on innovation output. Looking towards the 4th IR, is it time for Ireland to put on the gloves?
Thank you @ipha and @BernardMallee for a fruitful panel on how to turn Ireland into a Global Innovation Leader
Earlier last week Professor Meir Pugatch moderated the Global Leadership Forum at the BIO International Convention that was held at Boston, MA. The panel, titled “Can Boston’s DNA be Replicated Globally?” Read more on our site: https://t.co/XKQhiWjBxF
Professor Meir Pugatch spoke at the St. Petersburg International Economic Forum (SPIEF) in the panel: “Life Sciences in 2030: A New Era for Biotechnology” https://t.co/NoSqjxC7nD #biotechnology#PugatchConsilium#SPIEF2018
In Santiago de Chile, Daniel Coriat shared the results of the BCI 2017 with a distinguished audience at an event hosted by CIF, the local Chilean pharmaceutical trade association: https://t.co/38p4TiUHpr #BCI2017#PugatchConsilium
Professor Meir Pugatch spoke yesterday at the forum “Positioning Taiwan as an Asia-Pacific Biomedical R&D Hub” which took place the International Convention Center in Taipei, and included the Vice President of Taiwan and additional government officials. https://t.co/5JekeawzIZ
Daniel Coriat, Director at Pugatch Consilium presented in Bogota the
results of the latest BCI Index during an event celebrating 60 years of the
creation of Afidro, the Colombian trade association representing innovator
pharmaceutical companies.